Brief: China Resources Pharmaceutical Posts HY Net Profit Attributable For KPC Pharmaceuticals
Aug 22 (Reuters) - China Resources Pharmaceutical Group
Ltd 3320.HK :
* HY NET PROFIT ATTRIBUTABLE FOR KPC PHARMACEUTICALS
RMB229.5
MILLION
* HY REVENUE FOR KPC PHARMACEUTICALS RMB3.55 BILLION VERSUS
RMB3.77 BILLION
Further company coverage: 3320.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on China Resources Pharmaceutical
See all newsBrief: China Resources Pharmaceutical Group Declares Interim Dividend Of RMB0.087 Per Share
Brief: China Resources Pharmaceutical Says Tasly Pharmaceutical Posts HY Net Profit Attributable Of RMB 892.7 MLN
Brief: China Resources Pharmaceutical Group Says HY Revenue RMB 1.93 Billion For CR Jiangzhong
Brief: China Resources Pharmaceutical Group Posts HY Revenue RMB 1.64 Billion, Down 50.97% For KPC Pharmaceuticals
Brief: China Resources Pharmaceutical Says CR Boya Bio-Pharmaceutical Posts Quarterly Unaudited Revenue RMB 321.1 Million, Net Profit RMB 30.0 Million